C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 231/54 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 403/04 (2006.01) C07D 405/04 (2006.01) C07D 409/04 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2453594
The present invention relates to the synthesis of a new class of indeno[1,2- c]pyrazol-4-ones of formula (I) that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti- proliferative agents.
L'invention concerne la synthèse d'une classe d'indéno[1,2-c]pyrazol-4-ones de formule (I) qui sont des inhibiteurs potentiels de la classe des enzymes connues sous la dénomination de kinases dépendantes de la cycline, associées aux sous-unités catalytiques cdk1-7 et à leurs sous-unités de régulation dénommées cyclines A-G. L'invention concerne aussi une méthode de traitement du cancer, ou d'autres maladies proliférantes, par administration d'une quantité efficace, sur le plan thérapeutique, d'un de ces composés, ou d'une de leurs formes salines, acceptable sur le plan pharmaceutique. Dans une autre réalisation, il est possible de traiter le cancer, ou d'autres maladies proliférantes, par l'administration d'une combinaison efficace, sur le plan thérapeutique, d'un de ces composés et d'un ou plusieurs agents anticancéreux ou antiprolifératifs connus.
Carini David
Dimeo Susan
Nugiel David
Vidwans Anup
Yue Eddy
Bristol-Myers Squibb Pharma Company
Piasetzki & Nenniger Llp
LandOfFree
Acylsemicarbazides as cyclin dependent kinase inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylsemicarbazides as cyclin dependent kinase inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylsemicarbazides as cyclin dependent kinase inhibitors... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1452477